Sequent Scientific Ltd

Sequent Scien. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sequent Scientific Ltd

₹ 188 1.34%
04 Jul - close price
sequent.in BSE: 512529 NSE: SEQUENT
About

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

Key Points

Business segments
The company has 2 business segments: Formulation and API. [1]

Website BSE NSE
  • Market Cap ₹ 4,715 Cr.
  • Current Price ₹ 188
  • High / Low ₹ 241 / 111
  • Stock P/E 213
  • Book Value ₹ 28.1
  • Dividend Yield 0.00 %
  • ROCE 8.97 %
  • ROE 3.25 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 6.69 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 5.64% over past five years.
  • Company has a low return on equity of -2.98% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
384 341 338 375 367 333 346 329 361 390 369 391 402
350 339 335 365 370 341 331 307 329 348 330 356 355
Operating Profit 33 2 3 10 -3 -8 15 22 32 42 39 34 46
OPM % 9% 1% 1% 3% -1% -2% 4% 7% 9% 11% 11% 9% 12%
4 -2 1 3 -60 -23 10 7 -1 3 0 6 1
Interest 6 7 8 10 11 10 13 13 12 16 14 15 15
Depreciation 13 14 13 14 15 14 15 15 16 16 17 17 16
Profit before tax 18 -21 -18 -10 -89 -56 -3 1 3 12 8 8 16
Tax % 45% -27% -75% -4% 4% -38% 123% -617% 52% 24% 20% 20% 36%
10 -15 -4 -10 -92 -35 -7 11 1 9 6 6 10
EPS in Rs 0.36 -0.60 -0.15 -0.36 -3.75 -1.40 -0.34 0.33 -0.04 0.26 0.10 0.14 0.37
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
395 443 606 684 848 1,039 1,179 1,362 1,413 1,421 1,370 1,551
389 425 550 641 765 914 1,009 1,150 1,303 1,409 1,308 1,390
Operating Profit 6 18 56 43 83 125 170 212 109 12 61 162
OPM % 2% 4% 9% 6% 10% 12% 14% 16% 8% 1% 4% 10%
-54 48 14 9 436 9 10 -0 11 -58 -6 10
Interest 34 43 38 28 33 33 36 24 16 36 48 61
Depreciation 29 32 46 40 41 42 51 51 52 56 62 66
Profit before tax -110 -8 -14 -17 444 59 94 137 53 -138 -55 44
Tax % 1% 40% 19% -3% 3% 3% 13% 24% 15% -11% -46% 27%
-110 -12 -16 -16 431 57 82 104 45 -122 -30 32
EPS in Rs -8.09 -0.70 -0.78 -0.57 17.30 1.97 2.81 3.84 1.65 -4.86 -1.44 0.87
Dividend Payout % 0% 0% 0% 0% 1% 10% 0% 13% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 6%
3 Years: 3%
TTM: 13%
Compounded Profit Growth
10 Years: 46%
5 Years: -20%
3 Years: -18%
TTM: 206%
Stock Price CAGR
10 Years: 2%
5 Years: 15%
3 Years: 23%
1 Year: 43%
Return on Equity
10 Years: 8%
5 Years: 2%
3 Years: -3%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 27 30 48 49 49 49 50 50 50 50 50 50
Reserves 30 61 898 928 599 657 637 678 642 649 607 654
418 473 312 416 305 325 343 277 365 444 488 481
148 343 265 503 380 346 424 381 378 374 389 416
Total Liabilities 623 908 1,523 1,896 1,332 1,378 1,454 1,386 1,435 1,517 1,534 1,602
238 474 586 684 476 498 577 536 564 605 592 587
CWIP 43 39 24 33 18 23 13 31 12 55 16 15
Investments 0 59 428 428 239 180 171 83 38 0 4 0
342 336 485 751 599 677 693 737 821 856 922 1,000
Total Assets 623 908 1,523 1,896 1,332 1,378 1,454 1,386 1,435 1,517 1,534 1,602

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-45 -24 -0 -7 45 116 115 115 31 17 31 83
-81 -157 -310 -116 7 -68 -72 10 -94 -65 -6 -25
146 179 309 147 -57 -20 -43 -139 67 32 -1 -61
Net Cash Flow 20 -1 -2 24 -5 28 0 -14 4 -16 23 -2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 77 95 116 136 111 98 99 93 85 88 89 85
Inventory Days 175 153 164 165 125 134 132 139 160 152 166 173
Days Payable 198 147 175 208 127 141 133 119 119 107 125 115
Cash Conversion Cycle 54 101 105 93 110 92 98 112 126 132 131 143
Working Capital Days 47 57 99 79 86 77 74 88 106 112 114 113
ROCE % -4% 8% 2% 1% 40% 9% 12% 16% 6% -3% 0% 9%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.78% 52.76% 52.61% 52.61%
6.45% 6.57% 6.25% 5.89% 6.27% 6.03% 6.12% 6.16% 5.69% 6.45% 6.10% 6.05%
2.27% 2.79% 2.81% 2.92% 2.92% 3.23% 7.23% 7.59% 8.06% 9.99% 12.01% 12.82%
38.10% 37.48% 37.76% 38.00% 37.64% 37.57% 33.69% 33.29% 33.30% 30.63% 29.12% 28.36%
0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.17% 0.17% 0.17% 0.17% 0.16% 0.16%
No. of Shareholders 1,97,1761,93,9541,96,2311,91,8751,87,4741,84,5211,72,8531,66,5931,63,6931,54,6031,62,5741,58,152

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls